Surgical treatment for periacetabular metastatic lesions

Adult Male Complications Bone Cements -- therapeutic use Operative Time Blood Loss, Surgical Bone Neoplasms Metastasis Pelvis Curettage 03 medical and health sciences Postoperative Complications 0302 clinical medicine Surgical 80 and over Humans Blood Loss Curettage -- adverse effects Reconstructive Surgical Procedures Adjuvant Aged Pain Measurement Retrospective Studies Postoperative Complications -- etiology Aged, 80 and over Pelvic surgery Radiotherapy Cancer Pain -- etiology -- therapy Bone Cements Acetabulum Cancer Pain Middle Aged Plastic Surgery Procedures Bone Neoplasms -- complications -- radiotherapy -- secondary -- surgery 3. Good health Survival Rate Orthopédie Female Radiotherapy, Adjuvant
DOI: 10.1016/j.ejso.2017.03.018 Publication Date: 2017-04-08T16:47:05Z
ABSTRACT
Periacetabular bone metastasis present with severe pain and functional loss leading to a poor quality of life. Surgical treatment remains challenging.We reviewed all cases operated at our institution. We analyzed pain scores and functional status as well as complications and their risk factors.Thirty-five patients underwent curettage and cemented reconstruction. Mean surgical time was 168 min. Mean surgical blood losses were 3150 ml. Major complications were encountered in 23% and minor complications in 29% of cases. We found a significant pain relief (p < 0.0001) and improvement in functional status in the postoperative period (p < 0.0001). A Harrington grade 4 lesion was correlated with a higher complication rate (p-value = 0.002).In this series we were able to show that surgical management is an effective option in the treatment of metastatic bone disease to the pelvis. However, this treatment is very complex and associated with very high complication rates. Therefore, adequate patient selection and preoperative management is advocated.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (15)
CITATIONS (16)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....